Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives
Chunhua Yang,1 Didier Merlin1,2 1Institute for Biomedical Sciences, Center for Diagnostics and Therapeutics, Digestive Disease Research Group, Georgia State University, Atlanta, GA 30302, USA; 2Atlanta Veterans Affairs Medical Center, Decatur, GA 30033, USACorrespondence: Chunhua YangInstitute for B...
Guardado en:
Autores principales: | Yang C, Merlin D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/95dc47a1a78b441ea911f14b7f6894be |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery
por: Naz S, et al.
Publicado: (2019) -
Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy
por: Jia R, et al.
Publicado: (2021) -
Peptide-Based Drug Delivery Systems
por: Dmitriy Berillo, et al.
Publicado: (2021) -
Targeted delivery of doxorubicin to HER2 positive tumor models
por: Gomari H, et al.
Publicado: (2019) -
Drug Delivery to the Bone Microenvironment Mediated by Exosomes: An Axiom or Enigma
por: Samal S, et al.
Publicado: (2021)